Evidence map›Paper›PMID 40888761›Full record

Observational studyActa paediatrica (Oslo, Norway : 1992)2026

Development and Validation of Multivariable Machine-Learning Models for the Prediction of Multisystemic Inflammatory Syndrome Outcomes in Latin American Children.

Danilo Buonsenso, Luca Mastrantoni, Rolando Ulloa-Gutierrez, Jimena García-Silva, Gabriela Ivankovich-Escoto, Marco A Yamazaki-Nakashimada, Enrique Faugier-Fuentes, Olguita Del Águila, German Camacho-Moreno, Dora Estripeaut and 3 more

Abstract readObservational StudyValidation StudyMulticenter Study
In one paragraph

Observational study in Acta paediatrica (Oslo, Norway : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Danilo BuonsensoDepartment of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID 0000-0001-8567-2639
Luca MastrantoniMedical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0003-1853-4927
Rolando Ulloa-GutierrezServicio de Aislamiento Pediátrico, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", Caja Costarricense de Seguro Social (CCSS), San José, Costa Rica.ORCID 0000-0002-9157-9227
Jimena García-SilvaDepartamento de Pediatría, Hospital Universitario "José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
Gabriela Ivankovich-EscotoServicio de Inmunología y Reumatología Pediátrica, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", Caja Costarricense de Seguro Social (CCSS), San José, Costa Rica.ORCID 0000-0001-9675-3143
Marco A Yamazaki-NakashimadaDepartamento de Inmunología Clínica, Instituto Nacional de Pediatría, Ciudad de México, Mexico.ORCID 0000-0002-7609-3923
Enrique Faugier-FuentesServicio de Reumatología, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico.ORCID 0000-0001-7807-1296
Olguita Del ÁguilaUnidad de Infectología Pediátrica, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.ORCID 0000-0003-3085-0148
German Camacho-MorenoUnidad de Infectología Pediátrica, HOMI, Fundación Hospital Pediátrico La Misericordia & Departamento de Pediatría, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID 0000-0003-0472-798X
Dora EstripeautServicio de Infectología, Hospital del Niño Dr. José Renán Esquivel, Ciudad de Panamá, Panama.ORCID 0000-0002-2042-0817
Iván F Gutiérrez-TobarServicio de Infectología, Clínica Infantil Colsubsidio, Bogotá, Colombia.
Adriana H TremouletDepartment of Pediatrics, University of California San Diego (UCSD) & Rady Children's Hospital, San Diego, California, USA.
REKAMLATINA‐3 MIS‐C Study Group Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe aimed to develop and test machine learning algorithms for the prediction of severe outcomes associated with MIS-C.

methodAn observational ambispective cohort study was conducted including children aged from 1 month to 18 years old in 84 hospitals from the REKAMLATINA (Red de la Enfermedad de Kawasaki en America Latina) network diagnosed with MIS-C from 1st January 2020 to 31st June 2022. Multiple models were developed to predict four main outcomes: paediatric intensive care unit (PICU) admission, need for inotropes, need for mechanical ventilation, and death. Performance measures were accuracy for PICU admission, inotropes use and mechanical ventilation, and the area under the receiver operating characteristic curve (AUROC) for death. Variable contribution was analysed using Shapley Additive Explanations (SHAP) values.

resultsWe included 1303 children with a diagnosis of MIS-C. The model for the prediction of PICU admission (random forest [RF]) reached an accuracy of 0.80 (95% CI: 0.76-0.84), the model for inotrope use (RF) an accuracy of 0.86 (95% CI: 0.82-0.90), the model for mechanical ventilation (histogram-based gradient boosting [HBGB]) an accuracy of 0.84 (95% CI 0.80-0.88), and the model for death (RF) reached an AUROC of 0.85 (95% CI 0.77-0.93).

conclusionsWe developed and validated machine learning models for the prediction of MIS-C related outcomes that can help clinicians risk stratify patients to identify those most likely to have a severe outcome from MIS-C.

Indexed as

Machine LearningSystemic Inflammatory Response SyndromeAdolescentChildChild, PreschoolCOVID-19FemaleHumansInfantIntensive Care Units, PediatricLatin AmericaMaleRespiration, ArtificialCOVID‐19Latin AmericaMIS‐Cprediction modelsweb‐app

Identifiers

PMID40888761
PMCPMC12687682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.